ArticleJournal of thoracic disease2025

Correlation of inflammatory markers with progression-free survival in advanced lung cancer patients treated with immune checkpoint inhibitors in combination with chemotherapy: a real-world study.

Shijun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.